1. Home
  2. Labeler Index
  3. Camber Pharmaceuticals, Inc.
  4. 31722-393
  5. Product Images: Calcium Acetate

Product Images Calcium Acetate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Calcium Acetate NDC 31722-393 by Camber Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

667mg-60 Tab - 667mg 60ct Tab

667mg-60 Tab - 667mg 60ct Tab

This is a description of a medication called "Calcium Acetate Tablets, USP" used for the treatment of calcium deficiencies. It contains 667 mg of calcium acetate and is taken orally as directed by a physician. The medication is produced by Camber Pharmaceuticals and manufactured by InvaGen Innovations Pharmaceuticals in Hauppauge, NY. The medication should be stored at room temperature (25°C), and kept away from children. The packaging contains 60 tablets and is available by prescription only.*

Table 1 - Table1

Table 1 - Table1

This is a table showing the adverse reactions in patients with end-stage renal disease undergoing hemodialysis. It includes the preferred term for each reaction, the total number of adverse reactions reported, and the results of two different studies involving the use of calcium acetate. The first study was an open table study of three months and involved 98 patients receiving calcium acetate and 69 patients receiving a placebo. The second study was a double-blind, placebo-controlled, cross-over study of liquid calcium acetate that involved 167 patients. The table includes the number and percentage of patients who reported nausea, vomiting, and hypercalcemia for both calcium acetate and the placebo.*

Table 2 - Table2

Table 2 - Table2

This is a table showing the average levels of serum phosphorous and calcium at different time points during a study. The table includes values for pre-study, week 4, week 8, week 12, and the p-value. The mean values and standard errors are expressed. Ninety-one patients completed at least 6 weeks of the study. An ANOVA was used to determine the difference in values between the pre-study and the study completion time points.*

Table 3 - Table3

Table 3 - Table3

structure - structure

structure - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.